SCHEMBL11237503

SCHEMBL11237503

C#Cc1ccc(CC)c(Cl)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PYCR1 P32322 2/20 0.38
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36
GRIN2B Q13224 1/20 0.36
GRIN2C Q14957 1/20 0.36
GRIN3A Q8TCU5 1/20 0.36
CTRC Q99895 1/20 0.34
PGK1 P00558 1/20 0.33
TAS1R3 Q7RTX0 1/20 0.33
TAS1R1 Q7RTX1 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRA5 P31644 1/20 0.33
GABRA2 P47869 1/20 0.33
GABRB2 P47870 1/20 0.33
MAPK1 P28482 2/20 0.33
LMNA P02545 1/20 0.33
NLRP1 Q9C000 1/20 0.33
IDO1 P14902 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11234649 0.85 PYCR1 (0.39) PYCR1PGK1IDO1CYP1A2CYP3A4
SCHEMBL11227891 0.82 CTRC (0.40) PYCR1CTRCMEN1KMT2ATDP1
SCHEMBL11233297 0.80 TYR (0.40) PYCR1CTRCMEN1KMT2ATDP1
SCHEMBL24838245 0.80 PNMT (0.48) PYCR1IDO1CA12CA1CA2
SCHEMBL16961425 0.80 GRIN2D (0.36) PYCR1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL14107962 0.80 CYP2A6 (0.47) LMNAP2RX7NPC1RAB9A
SCHEMBL11226592 0.79 PYCR1 (0.35) PYCR1GABRA1GABRB2CYP1A2CYP3A4
SCHEMBL26016357 0.79 PYCR1 (0.35) PYCR1GABRA1GABRA5GABRA2GABRB2
SCHEMBL11231184 0.79 TSHR (0.42) CTRCMEN1KMT2ATDP1CYP3A4
SCHEMBL11240549 0.79 TSHR (0.42) CTRCMEN1KMT2ATDP1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4094995-A ETHYNYLBENZENE COMPOUNDS AND DERIVATIVES THEREOF TO TREAT PAIN, FEVER AND INFLAMMATION WILLIAM H. RORER, INC. (US) 1978-06-13 US claimed
US-20230173078-A1 SMARCA DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. 2023-06-08 US disclosed
WO-2017191098-A1 PYRAZOLE DERIVATIVES, COMPOSITIONS AND THERAPEUTIC USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2017-11-09 WO disclosed
EP-2069354-B1 Aza-benzofuranyl compounds and methods of use GENENTECH INC (US) 2011-11-02 EP disclosed
WO-2008157179-A2 N-SUBSTITUTED AZAINDOLES AND METHODS OF USE GENENTECH, INC. (US) 2008-12-24 WO disclosed
WO-2008024724-A1 AZA-BENZOTHIOPHENYL COMPOUNDS AND METHODS OF USE GENENTECH, INC. (US) 2008-02-28 WO disclosed
WO-2008024725-A1 AZA-BENZOFURANYL COMPOUNDS AND METHODS OF USE GENENTECH, INC. (US) 2008-02-28 WO disclosed
US-4365093-A Ethynylbenzene compounds and derivatives thereof WILLIAM H. RORER, INC. (US) 1982-12-21 US disclosed
US-4296264-A Ethynylbenzene compounds and derivatives thereof WILLIAM H. RORER, INC. (US) 1981-10-20 US disclosed
US-4288457-A Ethynylbenzene compounds and derivatives thereof WILLIAM H. RORER, INC. (US) 1981-09-08 US disclosed
US-4150148-A NITROSUBSTITUTED WILLIAM H. RORER, INC. (US) 1979-04-17 US disclosed
US-4120889-A Cyano ethynylbenzene compounds WILLIAM H. RORER, INC. (US) 1978-10-17 US disclosed
US-4120885-A Ethynylbenzene compounds and derivatives thereof WILLIAM H. RORER, INC. (US) 1978-10-17 US disclosed
US-4105786-A ANTIINFLAMMATORY WILLIAM H. RORER, INC. (US) 1978-08-08 US disclosed
US-4101591-A Ethynylbenzene compounds and derivatives thereof WILLIAM H. RORER, INC. (US) 1978-07-18 US disclosed
US-4096279-A Ethynylbenzene compounds and derivatives thereof in the treatment of pain fever and inflammation WILLIAM H. RORER, INC. (US) 1978-06-20 US disclosed
US-4094995-A ETHYNYLBENZENE COMPOUNDS AND DERIVATIVES THEREOF TO TREAT PAIN, FEVER AND INFLAMMATION WILLIAM H. RORER, INC. (US) 1978-06-13 US disclosed
US-4093737-A Ethynylbenzene compounds and derivatives thereof in the treatment of pain, fever or inflammation WILLIAM H. RORER, INC. (US) 1978-06-06 US disclosed
US-4075354-A ETHYNYLBENZENE COMPOUNDS AND DERIVATIVES THEREOF FOR TREATING PAIN FEVER AND INFLAMMATION WILLIAM H. RORER, INC. (US) 1978-02-21 US disclosed
US-3981932-A Ethynylbenzene compounds and derivatives thereof WILLIAM H. RORER, INC. (US) 1976-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230173078-A1 SMARCA DEGRADERS AND USES THEREOF SMARCA1, SMARCA2, SMARCC2 PYCR1 1942/4885GRIN2D 4810/4885GRIN3B 4737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.